-
公开(公告)号:US20070248668A1
公开(公告)日:2007-10-25
申请号:US11784051
申请日:2007-04-05
IPC分类号: A61K31/5383 , A61K31/535 , A61K31/355 , A61K31/22 , A61K31/07
CPC分类号: A61K31/535 , A61K9/4858 , A61K9/4866 , A61K31/355 , A61K31/538 , A61K31/5383 , A61K45/06 , A61K2300/00
摘要: The invention features pharmaceutical compositions including rifalazil, a surfactant, and a lipophilic antioxidant and methods of use thereof.
摘要翻译: 本发明的特征在于药物组合物,包括利拉拉齐,表面活性剂和亲脂性抗氧化剂及其使用方法。
-
公开(公告)号:US20070155715A1
公开(公告)日:2007-07-05
申请号:US11638756
申请日:2006-12-14
申请人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Joseph Raker , Xiang Yu , James Siedlecki , Yingfei Yang
发明人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Joseph Raker , Xiang Yu , James Siedlecki , Yingfei Yang
IPC分类号: A61K31/5383 , C07D491/22
CPC分类号: C07D498/18 , C07D519/00
摘要: The present invention features rifamycin analogs and methods of using these compounds to treat a variety of microbial infections.
摘要翻译: 本发明特征为利福霉素类似物和使用这些化合物治疗各种微生物感染的方法。
-
公开(公告)号:US20050143409A1
公开(公告)日:2005-06-30
申请号:US10948608
申请日:2004-09-23
申请人: Arthur Michaelis , Bernard Cabana
发明人: Arthur Michaelis , Bernard Cabana
IPC分类号: A61J20060101 , A61K31/33 , A61K31/4745 , A61K31/496 , A61K31/5415 , A61K31/70
CPC分类号: A61K31/33 , A61K31/475 , A61K31/496 , A61K31/5415 , A61K31/70
摘要: The invention features an ascending dose regimen for the administration of rifamycin-class antibiotics. The dosing regimen can be used to treat bacterial infections and diseases related to infection.
摘要翻译: 本发明的特征在于施用利福霉素类抗生素的上升剂量方案。 给药方案可用于治疗细菌感染和与感染有关的疾病。
-
公开(公告)号:US20050143374A1
公开(公告)日:2005-06-30
申请号:US11065267
申请日:2005-02-24
申请人: Arthur Michaelis , Hawkins Maulding
发明人: Arthur Michaelis , Hawkins Maulding
IPC分类号: C07D498/04 , A61K31/5415 , C07D498/02
CPC分类号: C07D498/04
摘要: The invention features compounds that act as antimicrobial agents and/or antimicrobial enhancer agents, compositions that include the antimicrobial enhancer agents of the invention, and methods for treating microbial infections using those compositions.
摘要翻译: 本发明的特征在于作为抗微生物剂和/或抗微生物增强剂的化合物,包括本发明的抗微生物增强剂的组合物,以及使用这些组合物治疗微生物感染的方法。
-
公开(公告)号:US20050123602A1
公开(公告)日:2005-06-09
申请号:US10950917
申请日:2004-09-27
申请人: Arthur Michaelis
发明人: Arthur Michaelis
IPC分类号: A61K20060101 , A61K9/107 , A61K9/48 , A61K9/64
CPC分类号: A61K9/107 , A61K9/4866
摘要: The invention features pharmaceutical compositions including rifalazil and a micelle-forming excipient and methods of use thereof.
摘要翻译: 本发明的特征在于药物组合物,包括利拉唑和胶束形成赋形剂及其使用方法。
-
公开(公告)号:US20050043298A1
公开(公告)日:2005-02-24
申请号:US10915919
申请日:2004-08-11
IPC分类号: C07D491/18 , C07D498/18 , C07D513/18 , C07D519/00 , A61K31/542 , A61K31/498 , A61K31/538 , C07D491/14 , C07D498/14
CPC分类号: C07D498/18 , C07D491/18 , C07D513/18 , C07D519/00
摘要: The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, 4′-and/or 6′ halo and/or alkoxy analogs, and various 5′ substituents that incorporate a cyclic amine moiety.
摘要翻译: 本发明的特征是利福霉素类似物可用作治疗或预防各种微生物感染的治疗剂。 在一种形式中,类似物在25位被乙酰化,就像利福霉素一样。 在另一种形式中,类似物在25位脱乙酰化。 在其他形式中,苯并恶嗪利霉素,苯并噻嗪可的霉素和苯并二氮松霉素类似物在苯环的不同位置衍生化,包括3'-羟基类似物,4'-和/或6'卤素和/或烷氧基类似物,以及各种5'取代基 加入环胺部分。
-
公开(公告)号:US20050197333A1
公开(公告)日:2005-09-08
申请号:US11020870
申请日:2004-12-22
申请人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Joseph Raker , Xiang Yu , James Siedlecki , Yingfei Yang
发明人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Joseph Raker , Xiang Yu , James Siedlecki , Yingfei Yang
IPC分类号: A61K31/498 , A61K31/5383 , A61K31/542 , A61P31/04 , A61P31/10 , C07D491/14 , C07D498/14 , C07D498/18 , C07D513/18 , C07D519/00
CPC分类号: C07D498/18 , C07D513/18 , C07D519/00
摘要: The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, 4′- and/or 6′ halo and/or alkoxy analogs, and various 5′ substituents that incorporate a cyclic amine moiety.
摘要翻译: 本发明的特征是利福霉素类似物可用作治疗或预防各种微生物感染的治疗剂。 在一种形式中,类似物在25位被乙酰化,就像利福霉素一样。 在另一种形式中,类似物在25位脱乙酰化。 在其他形式中,苯并恶嗪利霉素,苯并噻嗪可的霉素和苯并二氮霉素霉素类似物在苯环的不同位置衍生化,包括3'-羟基类似物,4'-和/或6'卤素和/或烷氧基类似物,以及各种5'取代基 加入环胺部分。
-
公开(公告)号:US20050137189A1
公开(公告)日:2005-06-23
申请号:US11008597
申请日:2004-12-09
申请人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Xiang Yu , James Siedlecki , Yingfei Yang
发明人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Xiang Yu , James Siedlecki , Yingfei Yang
IPC分类号: A61K20060101 , A61K31/395 , A61K31/498 , A61K31/4985 , A61K31/538 , A61K31/5383 , A61K31/5415 , A61K31/542 , A61P9/10 , A61P31/00 , A61P31/04 , A61P31/10 , C07D491/14 , C07D498/12 , C07D498/14 , C07D498/22 , C07D513/22 , C07D515/12 , C07D519/00
CPC分类号: C07D498/16 , C07D498/22 , C07D513/22
摘要: The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, and/or various fused ring systems with the benzene ring at the 4′,5′ or 5′,6′ positions.
摘要翻译: 本发明的特征是利福霉素类似物可用作治疗或预防各种微生物感染的治疗剂。 在一种形式中,类似物在25位被乙酰化,就像利福霉素一样。 在另一种形式中,类似物在25位脱乙酰化。 在其它形式中,苯并恶嗪利霉素,苯并噻嗪可霉素和苯并二氮霉素类似物在苯环的不同位置衍生化,包括3'-羟基类似物和/或各种稠合环体系,其中苯环为4',5'或5' ,6'位。
-
公开(公告)号:US20070238747A1
公开(公告)日:2007-10-11
申请号:US11804141
申请日:2007-05-17
申请人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Xiang Yu , James Siedlecki , Yingfei Yang
发明人: John van Duzer , Arthur Michaelis , William Geiss , Douglas Stafford , Xiang Yu , James Siedlecki , Yingfei Yang
IPC分类号: A61K31/4355 , C07D498/14 , C07D498/16
CPC分类号: C07D498/16 , C07D498/22 , C07D513/22
摘要: The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, and/or various fused ring systems with the benzene ring at the 4′,5′ or 5′,6′ positions.
摘要翻译: 本发明的特征是利福霉素类似物可用作治疗或预防各种微生物感染的治疗剂。 在一种形式中,类似物在25位被乙酰化,就像利福霉素一样。 在另一种形式中,类似物在25位脱乙酰化。 在其它形式中,苯并恶嗪利霉素,苯并噻嗪可霉素和苯并二氮霉素类似物在苯环的不同位置衍生化,包括3'-羟基类似物和/或各种稠合环体系,其中苯环为4',5'或5' ,6'位。
-
-
-
-
-
-
-
-